CNS Pharmaceuticals

CNS Pharmaceuticals embarked on a comprehensive rebranding initiative to better align its digital and visual identity with its role as a leader in glioblastoma research. This strategic overhaul included the creation of a new logo inspired by neural networks, development of essential printed materials, and bespoke medical illustrations to enhance communication. Additionally, the project encompassed a complete redesign of their website with a strong focus on advanced UI/UX and accessibility standards, complemented by a custom, self-hosted investor relations site to foster streamlined, independent communications.

The rebranding challenge was multifaceted, requiring a cohesive and engaging update across all digital and visual platforms to adequately reflect CNS Pharmaceuticals' innovative approach to glioblastoma treatments. By integrating these elements—ranging from graphic design to Craft CMS development—the revamped identity not only supports their pioneering research but also ensures a unified, professional brand experience for all stakeholders.